Hunting for the Off-Target Properties of Ticagrelor on Endothelial Function and Other Circulating Biomarkers in Humans

Trial Profile

Hunting for the Off-Target Properties of Ticagrelor on Endothelial Function and Other Circulating Biomarkers in Humans

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Feb 2017

At a glance

  • Drugs Ticagrelor (Primary) ; Clopidogrel; Prasugrel
  • Indications Acute coronary syndromes
  • Focus Therapeutic Use
  • Acronyms Hi Tech
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 10 Feb 2017 Status changed from active, no longer recruiting to completed.
    • 04 Nov 2016 Planned End Date changed from 1 Dec 2016 to 1 Apr 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top